Indian Journal of Medical Biochemistry

Register      Login

VOLUME 21 , ISSUE 2 ( July-December, 2017 ) > List of Articles


Glucose Fluctuations and Activation of Oxidative Stress in Patients with Type II Diabetes Mellitus

Reenu Sharma, Sunil S Patani, Maulik S Nayak

Citation Information : Sharma R, Patani SS, Nayak MS. Glucose Fluctuations and Activation of Oxidative Stress in Patients with Type II Diabetes Mellitus. Indian J Med Biochem 2017; 21 (2):124-126.

DOI: 10.5005/jp-journals-10054-0034

License: CC BY 3.0

Published Online: 01-12-2013

Copyright Statement:  Copyright © 2017; The Author(s).



In recent years, the oxidative stress (OS)-induced free radicals have been implicated in the pathology of diabetes mellitus (DM). Persistently high glucose levels can lead to the generation of higher amounts of free radicals. The purpose of the present study was to evaluate the role of hyperglycemia [by measuring variables: Glycated hemoglobin (HbA1c), fasting plasma glucose (FPG)] in the induction of OS [(by analyzing the OS marker: Malondialdehyde (MDA)] in type II DM.

Materials and methods

This observational study was conducted among 50 type II DM patients without complications and 50 type II DM patients with complications in S.B.K.S. Medical Institute and Research Centre, Waghodiya, Gujarat, India. Correlations between variables were tested using the Pearson rho correlation test. Chi-squared (χ2) analysis was used for comparison of groups.


The MDA values correlated significantly with HbA1c and FPG values in type II diabetic subjects with complications (r = +0.29, p = 0.04; r = +0.47, p = 0.0006).


Glucose fluctuations may activate OS in DM. Assessment of glycemic control marker HbA1c and lipid peroxidation marker MDA is useful in DM patients for detection of risk of diabetic complications at an early stage of the disease.

How to cite this article

Nayak MS, Sharma R, Patani SS. Glucose Fluctuations and Activation of Oxidative Stress in Patients with Type II Diabetes Mellitus. Indian J Med Biochem 2017;21(2):124-126.

  1. Prevalence of vascular complications and their risk factors in type 2 diabetes. JAPI 1999 Dec;47(12):1152-1156.
  2. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005 May-Jun;19(3):178-181.
  3. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 2000 Sept;58(Suppl 77):S19-S25.
  4. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta 1978 Nov;90(1):37-43.
  5. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969;6:24.
  6. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971 Feb;284(7):353-357.
  7. Glucose variability: comparison of different indices during continuous glucose monitoring in diabetic patients. J Diabetes Sci Technol 2016 Jun;10(4):885-891.
  8. Clinical implications of glucose variability: chronic complications of diabetes. Endocrinol Metab 2015 Jun;30(2):167-174.
  9. Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? Int J Mol Sci 2014 Oct;15(10):18381-18406.
  10. Management of critically ill patients with diabetes. World J Diabetes 2017 Mar;8(3):89-96.
  11. Stress hyperglycemia: an essential survival response! Crit Care 2013 Mar;17(2):305.
  12. Glucagon orchestrates stress-induced hyperglycaemia. Diabetes Obes Metab 2016;18:648-653.
  13. Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: The ADVANCE trial. Diabetes Care 2014 Aug;37(8):2359-2365.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.